Close

Iovance Biotherapeutics (IOVA) Announces Clinical Data Updates for Lifileucel in Advanced Melanoma During AACR

Go back to Iovance Biotherapeutics (IOVA) Announces Clinical Data Updates for Lifileucel in Advanced Melanoma During AACR
(NASDAQ: IOVA) Delayed: 11.32 +0.01 (0.09%)
Previous Close $11.31    52 Week High
Open $11.54    52 Week Low
Day High $11.64    P/E N/A 
Day Low $11.07    EPS
Volume 2,404,926